Next Article in Journal
Relationship between Structure of Phenolics and Anticancer Activity
Previous Article in Journal
Can Curcumin be Employed to Promote the Integration of Oncology and Natural Products?
Article Menu
Issue 10 (NPCPT 2017) cover image

Article Versions

Export Article

Open AccessAbstract
Proceedings 2017, 1(10), 979;

Growth Factors Responsible from the Cancer Progress: Role of Natural Products

Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri 38039, Turkey
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
Published: 13 November 2017
PDF [138 KB, uploaded 13 November 2017]


Growth factors are one of the main factors responsible from the uncontrolled cell progress in cancer. Up to date many scientists have focused on these factors either as the marker or as the targets in several cancer types. Mainly the drugs are designed to target these factors are monoclonal antibodies. Nerve growth factor (NGF), epidermal growth factor (EGF), hepatocyte growth factors (HGF), fibroblast growth factors (FGF), vascular endothelial growth factors (VEGF), platelet derived growth factor (PDGF), transforming growth factor (TGF-β) are some of these factors not only increasing the ability of cell proliferation but also playing crucial roles in triggering the invasion and metastasis of the cells. The herbs that are traditionally used for anticancer treatment and target multiple interdependent processes. Given the multiple effects of these agents, their future use for cancer therapy probably lies in synergistic combinations. For instance, Artemisia annua, Viscum album, Curcuma longa, Camellia sinensis, Vitis vinifera, Angelica sinensis, Taxus brevifolia, are some of the herbs that has shown to affect VEGF and those which have additional effects on the molecules related to cancer progress and further can target other growth factors. During active cancer therapy, they should generally be evaluated in combination with chemotherapy and radiation. In this role, they act as modifiers of biologic response, potentially enhancing the efficacy of or reducing the resistance to the conventional therapies.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Yerer, M.B. Growth Factors Responsible from the Cancer Progress: Role of Natural Products. Proceedings 2017, 1, 979.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Proceedings EISSN 2504-3900 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top